Oxybutynin Chloride Tablet
Product Images NDC 23155-810

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 23155-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

This Is An Image Of The Structural Formula For Oxybutynin Chloride. (8be54c67 6800 4c7f 9cbb 0a38b5511250 01)

Chemical structure of Oxybutynin Chloride shown as a detailed molecular diagram with rings, chains, and functional groups, including benzene and cyclohexane rings, an ester linkage, and a quaternary ammonium ion with chloride.*

FDA Label Image

Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers (8be54c67 6800 4c7f 9cbb 0a38b5511250 02)

A line graph depicting mean plasma R-oxybutynin concentration (ng/mL) over 24 hours following administration of 5 mg oxybutynin three times daily (TID). The x-axis represents time in hours, and the y-axis represents concentration. The graph shows three peak concentration periods corresponding roughly to dosing times.*

FDA Label Image

Oxy 3 (8be54c67 6800 4c7f 9cbb 0a38b5511250 03)

A line graph showing the mean plasma concentration of R-Oxybutynin (ng/mL) over time (hours) after administration. The X-axis represents time from 0 to 12 hours, and the Y-axis shows plasma concentration from 0 to 10 ng/mL. Data points indicate a peak concentration just after 1 hour, followed by a gradual decline to nearly baseline by 12 hours, with error bars at each point.*

FDA Label Image

Image (8be54c67 6800 4c7f 9cbb 0a38b5511250 04)

Oxybutynin Chloride Tablets USP, 5 mg, oral tablets packaged by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. The label includes dosage instructions, warnings, storage conditions, and manufacturer information (Strides Pharma Science Ltd., India). The label specifies the product NDC 23155-810-01 and package count of 100 tablets. It states the product is prescription only and includes barcodes and lot, expiration details placeholders.*

FDA Label Image

5mg-500s (8be54c67 6800 4c7f 9cbb 0a38b5511250 05)

Oxybutynin Chloride Tablets, USP 5 mg oral tablets label showing a bottle of 500 tablets for prescription use only. The label lists the active ingredient as oxybutynin chloride, 5 mg per tablet, and includes manufacturer information for Strides Pharma Science Ltd. and distributor Avet Pharmaceuticals Inc. Additional details include dosage instructions, storage conditions, and safety warnings.*

FDA Label Image

5mg-1000s (8be54c67 6800 4c7f 9cbb 0a38b5511250 06)

Oxybutynin Chloride Tablets, USP, 5 mg, oral tablets labeled by Avet Pharmaceuticals Inc. The label states 1000 tablets per container, prescription use only, and includes usage directions, storage conditions (20° to 25°C), and warnings. Manufactured by Strides Pharma Science Ltd. in India and distributed by Avet Pharmaceuticals Inc. in East Brunswick, NJ. Includes barcodes and regulatory text.*

FDA Label Image

Image (8be54c67 6800 4c7f 9cbb 0a38b5511250 79 1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.